Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M McDonald

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 2012
Exacerbations of severe asthmaV M McDonald, P G Gibson
Chronic Respiratory Disease|March 3, 2006
Asthma self-management educationV M McDonald, P G Gibson
Internal Medicine Journal|March 15, 2011
Multicentre audit of inpatient management of acute exacerbations of chronic obstructive pulmonary disease: comparison with clinical guidelinesJ J Pretto, V M McDonald, P A B Wark, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 24, 2013
Sputum ADAM8 expression is increased in severe asthma and COPDK M Oreo, P G Gibson, J L Simpson, et al.
The European Respiratory Journal|September 17, 2011
Soluble RAGE is deficient in neutrophilic asthma and COPDM B Sukkar, L G Wood, M Tooze, et al.
Internal Medicine Journal|June 29, 2016
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair RegistryP G Gibson, H Reddel, V M McDonald, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 6, 2016
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteriaM Hew, A Gillman, M Sutherland, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 2018
Working while unwell: Workplace impairment in people with severe asthmaS A Hiles, E S Harvey, V M McDonald, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 2012
Exacerbations of severe asthmaV M McDonald, P G Gibson
Chronic Respiratory Disease|March 3, 2006
Asthma self-management educationV M McDonald, P G Gibson
Internal Medicine Journal|March 15, 2011
Multicentre audit of inpatient management of acute exacerbations of chronic obstructive pulmonary disease: comparison with clinical guidelinesJ J Pretto, V M McDonald, P A B Wark, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 24, 2013
Sputum ADAM8 expression is increased in severe asthma and COPDK M Oreo, P G Gibson, J L Simpson, et al.
The European Respiratory Journal|September 17, 2011
Soluble RAGE is deficient in neutrophilic asthma and COPDM B Sukkar, L G Wood, M Tooze, et al.
Internal Medicine Journal|June 29, 2016
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair RegistryP G Gibson, H Reddel, V M McDonald, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 6, 2016
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteriaM Hew, A Gillman, M Sutherland, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 2018
Working while unwell: Workplace impairment in people with severe asthmaS A Hiles, E S Harvey, V M McDonald, et al.
Pageof 1